Publications by Mayo B. Alao

< back to bio

Black Health Care Executive Spotlight | Kurt Strudwick

[07/08/25]

Telehealth March Madness: Medicare Waivers Extended While DEA Rules Get Benched

[03/26/25]

Montana Supreme Court Affirms HCQIA Immunity for Hospital Peer Review

[03/03/25]

DEA Publishes Long-Awaited Rules for Telemedicine Prescribing

[01/22/25]

Congress Passes Extension to Key Telehealth Payment Policies

[12/24/24]

DEA and HHS Announce Third Extension of COVID-Era Telemedicine Flexibilities for Controlled Substance Prescribing  

[11/20/24]

CMS Finalizes Graduate Medical Education Changes in 2025 IPPS Final Rule

[08/29/24]

DEA and HHS Extend COVID-19 Telemedicine Flexibilities for Controlled Medications Prescriptions Again

[10/12/23]

"How Telemedicine Providers Can Adapt To Post-COVID Rules." Law360, June 2023

DEA & SAMHSA Issue Temporary Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Substances Prescribing Beyond the Termination of COVID-19 PHE

[05/09/23]

CMS COVID-19 Vaccine Mandate is Here to Stay: Four Key Takeaways for the Organized Medical Staff

[05/11/22]

"The Complete Medical Staff, Peer Review, and Hearing Guidebook." AHLA, March 2022.

[03/29/2022]

New Grant Funding Available from the CDC for Plans to Address Social Determinants of Health

[05/26/21]

HHS Modifies PREP Act Declaration to Expand Telehealth

[12/04/20]

Court Rules that Hospital Price Transparency Requirements Can Take Effect

[06/26/20]

The Organized Medical Staff in Health Care M&A: Three Key Considerations for Avoiding Unnecessary Surprises and Delays

[06/04/20]

OIG Approves Beneficiary Discounts and Premium Credits for Medigap Plan Using Preferred Hospital Networks

[12/20/16]

AHRQ Issues Guidance for Patient Safety Organizations on Patient Safety Work Product and External Reporting Obligations

[07/01/16]

OIG Approves Free Patient Transportation Service in Favorable Advisory Opinion

[11/04/15]

Thirty-Eight Years and Counting: The FDA's Misuse of the 510(k) Notification Process and the Consequent Under Regulation of Implantable Medical Devices, 8 St. Louis U. J. Health L. Pol'y 347 (2015).